Properties:
PT-141, also known as Bremelanotide, is a potent peptide primarily known for its effects on sexual function. Originally developed as a treatment for sexual dysfunction, PT-141 has gained recognition for its ability to enhance libido and sexual performance in both men and women. Unlike other treatments that target the vascular system, PT-141 works directly through the nervous system, making it a unique and effective option for those seeking to improve their sexual health. PT-141’s mechanism involves activating melanocortin receptors in the brain, which leads to increased sexual arousal and desire without affecting blood flow.
Mechanism of action:
The action of PT-141 revolves around its ability to stimulate melanocortin receptors, particularly the MC4R subtype, in the central nervous system. These receptors are involved in regulating a wide array of functions, including sexual behavior and energy homeostasis. By binding to these receptors, PT-141 triggers a cascade of neurochemical events that enhance sexual arousal. This mechanism is distinct from that of other sexual enhancement drugs, which often focus on increasing blood flow to the genital area. PT-141’s selective action on the brain’s sexual pathways allows for a more natural response, enhancing libido without the cardiovascular effects associated with other treatments.
Benefits:
Regular use of PT-141 in research settings has shown to result in a noticeable increase in sexual desire and performance. For men, this can mean improved erectile function and heightened sexual satisfaction, while women may experience enhanced arousal and orgasmic response. Additionally, PT-141 has been observed to have potential mood-stabilizing effects, contributing to a general sense of well-being. The compound is particularly beneficial for individuals experiencing sexual dysfunction due to psychological factors or those who are unresponsive to traditional treatments like PDE5 inhibitors.
Why Powerock Pharma:
At Powerock Pharma, our commitment to excellence ensures that every batch of PT-141 is produced in compliance with the highest industry standards, including GMP, HACCP, and ISO 13485. Our rigorous testing processes guarantee the purity, potency, and safety of our products, providing researchers with reliable results. We partner with leading laboratories to validate every aspect of our production, so you can trust that PT-141 from Powerock Pharma will consistently deliver the expected outcomes. Choosing Powerock Pharma means choosing a product backed by science, quality, and integrity.
Summary:
If you’re seeking to explore the potential of enhanced sexual function through research, PT-141 is an invaluable tool. With Powerock Pharma’s stringent quality controls, you can confidently conduct your studies, knowing that you’re working with the best. Don’t compromise on your research—order PT-141 today and unlock the full potential of your study’s outcomes.
Chromatogram PT141
Research Method PT141
| Time | H20 + 0,1% TFA | ACN + 0,1% TFA |
|---|
| 0min | 95% | 5% |
| 2min | 95% | 5% |
| 12min | 5% | 95% |
| 15min | 5% | 95% |
How to use PT141
How to take:
PT-141 (Bremelanotide) should be administered via subcutaneous injection for research purposes. It is crucial to use bacteriostatic water to reconstitute the peptide before administration. Ensure that all handling and preparation are done under sterile conditions to maintain the integrity of the compound.
When to take:
For optimal results in research studies, PT-141 should be administered approximately 1-2 hours before the anticipated effect is desired, allowing time for the compound to take effect. Administration frequency can vary depending on the specific research protocol, but typically, it is administered on an as-needed basis.
Cycle length:
The recommended cycle length for research studies involving PT-141 is generally around 8-12 weeks. This period allows sufficient time to observe the effects and gather comprehensive data on the compound’s efficacy and safety. It is advisable to follow the research protocol closely and adjust the cycle length based on the study’s objectives and observed outcomes.
Dosage for women:
For research involving female subjects, a starting dosage of 0.75 mg is recommended. Depending on the specific goals and response, this dosage may be adjusted. Careful monitoring is essential to ensure optimal results and to minimize any potential side effects.
Dosage for men:
For male subjects, a typical dosage of 1.0 mg is used in research settings. Adjustments may be made based on individual response and study requirements. As with female subjects, continuous monitoring is important to ensure accurate data collection and safety.
Monitoring:
Continuous monitoring of research subjects is crucial throughout the study to document effects, manage any adverse reactions, and adjust dosages if necessary. Regular check-ins and data collection at intervals help ensure that the research is on track and that the safety of subjects is maintained.
How to Stack PT141
PT-141 + Oxytocin:
This combination is highly effective for enhancing sexual function and emotional bonding. Oxytocin, known as the “love hormone,” complements PT-141 by amplifying feelings of intimacy and connection. Together, they enhance the overall sexual experience, making it more fulfilling and emotionally satisfying.
PT-141 + Sildenafil (Viagra):
For research focusing on erectile dysfunction, PT-141 can be stacked with Sildenafil. While PT-141 works on the central nervous system to increase libido, Sildenafil addresses vascular issues by enhancing blood flow to the genital area. This combination provides a comprehensive approach to sexual dysfunction.
PT-141 + Melanotan II:
This stack is ideal for studies exploring sexual function alongside skin tanning. Melanotan II, like PT-141, is a melanocortin receptor agonist and may complement the effects of PT-141 on sexual arousal while also providing the additional benefit of skin pigmentation.
PT-141 + GABA:
To study the effects of relaxation and reduced anxiety in conjunction with sexual arousal, PT-141 can be stacked with GABA. This combination may help subjects achieve a calm state of mind while enhancing sexual desire, offering potential insights into the management of performance anxiety.
PT-141 + L-DOPA:
For research focused on dopamine-related sexual function, PT-141 can be combined with L-DOPA. This stack may provide insights into how increased dopamine levels, alongside melanocortin receptor activation, affect sexual behavior and motivation.
Frequently Asked Questions About PT141
What is the recommended dosage for research purposes?+
The recommended dosage of PT-141 for research purposes is typically 0.75 mg for women and 1.0 mg for men, administered via subcutaneous injection. Dosage adjustments should be made based on the research protocol and individual response.
Can this product be used in combination with other compounds?+
Yes, PT-141 can be used in combination with other compounds, such as Oxytocin, Sildenafil, Melanotan II, GABA, or L-DOPA, depending on the specific goals of the research. Stacking PT-141 with these compounds may enhance or complement its effects, providing valuable insights into sexual function and related behaviors.
What are the potential side effects observed in research?+
In research settings, potential side effects of PT-141 may include nausea, flushing, headache, and injection site reactions. These effects are generally mild and transient, but careful monitoring is advised to manage any adverse reactions promptly.
Is this product safe for long-term research?+
While PT-141 has shown promise in short- to medium-term studies, its safety for long-term research requires further investigation. It is recommended to adhere to established research protocols and continuously monitor subjects for any signs of adverse effects during prolonged studies.
How should this product be stored?+
PT-141 should be stored in a cool, dry place, away from direct sunlight. After reconstitution with bacteriostatic water, the solution should be stored in a refrigerator at 2-8°C and used within 30 days. Ensure that the vial is sealed tightly to prevent contamination.
What makes Powerock Pharma products reliable for research?+
Powerock Pharma ensures that every batch of PT-141 is manufactured under strict quality controls, meeting GMP, HACCP, and ISO 13485 standards. Our commitment to purity, potency, and consistency, coupled with rigorous testing protocols, makes our products reliable and trustworthy for research purposes.
English 
German 
Spanish 
French 
Czech 
Polish 
Ukrainian 